Close Menu

Grants

Additional funding opportunities

Research Funding Opportunities

Tools to Find Funding

Grants Awarded for Health Sciences Research

Title Type $ Amount Activity Investigator Unit Sponsorsort descending Date
Effect of Myostatin Inhibition on Muscle Size and Muscle Function in a Novel Mouse Model of Typical Nemaline Myopathy Grant $124,635.00 Research Hendrikus Granzier Cellular & Molecular Medicine A Foundation Building Strength 12/2020
Percutaneous or Surgical Mitral Valve REpair in PAtients with PrImaRy Mitral Regurgitation Whose Mitral Valve has been Determined to be suitable for correction by MV repair Surgery (REPAIR MR) Contract $230,208.00 Clinical Trial Marvin Eng COM Phx Internal Medicine Abbott Laboratories 12/2021
Clinical TRIal to EvaLUate Cardiovascular OutcoMes IN PAtients Treated with the Tricuspid ValvE Repair System Pivotal (TRILUMINATE Pivotal) Contract $184,057.72 Clinical Trial Divya Verma COM Phx Internal Medicine Abbott Laboratories 03/2021
Dorsal spInal cord STImulatioN vs mediCal management for the Treatment of low back pain (DISTINCT) Contract $545,762.00 Clinical Trial Mohab Ibrahim Anesthesiology Abbott Laboratories 03/2021
A Phase 3, Multicenter, Randomized, Open Label Study of Venetoclax and Dexamethasone Compared with Pomalidomide and Dexamethasone in Subjects with t(11;14)-Positive Relapsed or Refractory Multiple... Contract $392,700.50 Clinical Trial Krisstina Gowin Cancer Center Division AbbVie Incorporated 07/2020
A Phase 1b, Dose Escalation and Expansion Study of Lemzoparlimab (TJ011133) With or Without Dexamethasone and in Combination With Anti-Myeloma Regimens for the Treatment of Patients With Relapsed/Refr Contract $1,799,212.70 Clinical Trial Muhammad Husnain Cancer Center Division AbbVie Incorporated 01/2022
A Phase 1 Study Evaluating the Safety, Pharmacokinetics, and Anti-Tumor Activity of ABBV-321 in Subjects with Advanced Solid Tumors Associated with Overexpression of the Epidermal Growth Factor Recept Contract $854,975.00 Clinical Trial Hani Babiker Cancer Center Division AbbVie Incorporated 10/2020
Phase 3b Study for Evaluation of Efficacy and Nutritional Benefits of Pancrelipase in Patients with Exocrine Pancreatic Insufficiency due to Periampullary and Pancreatic Cancer Contract $122,409.40 Clinical Trial Hani Babiker Cancer Center Division AbbVie Incorporated 01/2020
CREON (Pancrelipase) Therapy for Subjects with Exocrine Pancreatic Insufficiency (EPI) due to Pancreatic Cancer: A Double-Blind, Randomized, Parallel Design with 2 Dose Cohorts of Pancrelipase... Contract $117,787.55 Clinical Trial Jen-Jung Pan COM Phx Internal Medicine AbbVie Incorporated 08/2020
Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial Contract $113,035.00 Clinical Trial Deepak Acharya Sarver Heart Center ABIOMED, Inc. 08/2020
Alternative Anticoagulant and Biocompatibility Study & Heparin-Impella Surface Interaction with Heparin-Containing Purge Solutions Contract $288,559.00 Research Marvin Slepian UAHS Research ABIOMED, Inc. 11/2020
Independent Hemocompatibility Assessment of ABIOMED Mechanical Circulatory Support Devices: Hemolysis and Platelet Activation Studies Contract $600,000.00 Research Marvin Slepian UAHS Research ABIOMED, Inc. 02/2022
Applied Research to Address the Coronavirus (COVID-19) Emerging Public Health Emergency Contract $10,000.00 Research Jefferey Burgess Community Environment & Policy Abt Associates 05/2020
Phase II Pilot Study of FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-Type, Left-Sided Colorectal Cancer Contract $127,173.74 Clinical Trial Aaron Scott Cancer Center Division Academic Gastrointestinal Cancer Consortium 03/2020
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy fo Contract $989,638.00 Clinical Trial Franz Rischard Medicine Acceleron Pharmaceuticals 01/2022
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy in Newly Diagnosed Intermediate- and High-r Contract $930,117.52 Clinical Trial Franz Rischard Medicine Acceleron Pharmaceuticals 02/2022
An Open-Label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH Contract $447,126.32 Clinical Trial Franz Rischard Medicine Acceleron Pharmaceuticals 01/2022
A Phase 2, Double-blind, Randomized, Placebocontrolled Study to Evaluate the Effects of Sotatercept versus Placebo for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension( Contract $2,048,686.48 Clinical Trial Franz Rischard Medicine Acceleron Pharmaceuticals 04/2022
AcQMap Pulmonary Vein Isolation Plus Left Atrial Slow Zone Mapping and Ablation (PLASZMA) Contract $158,922.40 Clinical Trial Jonathan Weiss COM Phx Internal Medicine Acutus Medical, Inc. 03/2021
AcQMap US Registry of Procedural and Long-term Clinical Outcomes (Discover-US) Contract $59,455.52 Clinical Trial Wilber Su COM Phx Internal Medicine Acutus Medical, Inc. 03/2021
iCLAS for Persistent Atrial Fibrillation Contract $193,319.94 Clinical Trial Wilber Su COM Phx Internal Medicine Adagio Medical, Inc 02/2021
Enhancing the Public Health Workforce with the Skills and Resources to Provide Culturally Responsive Services for Individuals with Developmental Disabilities in Arizona Grant $113,670.00 Other Sponsored Activity Wendy Parent-Johnson Family and Community Medicine Administration for Community Living 04/2022
Finds Their Way: Communities for Youth Transition Grant $223,385.00 Other Sponsored Activity Wendy Parent-Johnson Family and Community Medicine Administration for Community Living 11/2021
Increasing COVID Vaccines for the People with Disabilities and Underserved Communities Grant $59,701.00 Research Training Wendy Parent-Johnson Family and Community Medicine Administration for Community Living 05/2021
Sonoran University Center for Excellence in Developmental Disabilities (UCEDD) Grant $577,449.00 Research Training Wendy Parent-Johnson Family and Community Medicine Administration for Community Living 08/2021

Pages